fda stop tirzepatide Friendly Reminder 💡 The only FDA‑approved U.S. brands of are Mounjaro and Zepbound. All tirzepatide available locally in the Philippines comes from the grey market. Even if tested in U.S. labs Friendly Reminder 💡 The only

Coverage Baseline Previously unavailable under Medicare Part D Only 13 states cover them in Medicaid (KFF HMA survey) 19% of large employers cover GLP-1s for obesity, though 43% of employers with 5,000+ employees offer coverage (KFF 2025 survey) Current Expansion ~50% of CVS Caremark clients now provide coverage for weight loss Medicare GLP-1 Bridge program launches coverage for eligible Medicare Part D patients 7/1/26 This aligns with a recent survey from Business Group on Health that found 67% of the surveyed employers now cover GLP-1s for weight loss (though a reduction is expected for 2027)

Bariatric surgery is the most effective intervention for weight loss in obese patients, and it leads to improvement in multiple obesity-related conditions, including remission of diabetes.

Prices starting from $99

Botox, hormone therapy, microneedling, weight loss solutions, and more

Compounding pharmacies offer copycat weight-loss drugs to millions, although FDA spokesperson warns against potential contamination or counterfeit.

Call us (281) 609-4439 for more info.